Literature DB >> 27342419

Risk of neuroblastoma, birth-related characteristics, congenital malformations and perinatal exposures: A pooled analysis of the ESCALE and ESTELLE French studies (SFCE).

Paula Rios1,2, Helen D Bailey1,2, Laurent Orsi1,2, Brigitte Lacour1,2,3, Dominique Valteau-Couanet4, Dominique Levy5, Nadège Corradini6, Guy Leverger7, Anne-Sophie Defachelles8, Marion Gambart9, Nicolas Sirvent10, Estelle Thebaud11, Stéphane Ducassou12, Jacqueline Clavel1,2.   

Abstract

Neuroblastoma (NB), an embryonic tumour arising from neural crest cells, is the most common malignancy among infants. The aetiology of NB is largely unknown. We conducted a pooled analysis to explore whether there is an association between NB and preconception and perinatal factors using data from two French national population-based case-control studies. The mothers of 357 NB cases and 1783 controls younger than 6 years, frequency-matched by age and gender, responded to a telephone interview that focused on demographic, socioeconomic and perinatal characteristics, childhood environment, life-style and maternal reproductive history. Unconditional logistic regression was used to estimate pooled odds ratios and 95% confidence intervals. After controlling for matching variables, study of origin and potential confounders, being born either small (OR 1.4 95% CI 1.0-2.0) or large (OR 1.5 95% CI 1.1-2.2) for gestational age and, among children younger than 18 months, having congenital malformations (OR 3.6 95% CI 1.3-8.9), were significantly associated with NB. Inverse associations were observed with breastfeeding (OR 0.7 95% CI 0.5-1.0) and maternal use of any supplements containing folic acid, vitamins or minerals (OR 0.5 95% CI 0.3-0.9) during the preconception period. Our findings reinforce the hypothesis that fetal growth anomalies and congenital malformations may be associated with an increased risk of NB. Further investigations are needed in order to clarify the role of folic acid supplementation and breastfeeding, given their potential importance in NB prevention.
© 2016 UICC.

Entities:  

Keywords:  childhood cancer; congenital malformations; fetal growth; neuroblastoma; risk factors

Mesh:

Year:  2016        PMID: 27342419     DOI: 10.1002/ijc.30239

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

Review 1.  Pediatric cancer risk in association with birth defects: A systematic review.

Authors:  Kimberly J Johnson; Jong Min Lee; Kazi Ahsan; Hannah Padda; Qianxi Feng; Sonia Partap; Susan A Fowler; Todd E Druley
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

Review 2.  Association between maternal breastfeeding and risk of systemic neoplasms of offspring.

Authors:  Qin-Qin Gong; Dan-Dan Quan; Chong Guo; Chao Zhang; Zhi-Jun Zhang
Journal:  Ital J Pediatr       Date:  2022-06-16       Impact factor: 3.288

3.  Increased incidence of childhood lymphoma in children with a history of small for gestational age at birth.

Authors:  Roy Kessous; Eyal Sheiner; Guy Beck Rosen; Joseph Kapelushnik; Tamar Wainstock
Journal:  Arch Gynecol Obstet       Date:  2022-02-08       Impact factor: 2.493

4.  Results of neuroblastoma treatment in Lithuania: a single centre experience.

Authors:  Austėja Juškaitė; Indrė Tamulienė; Jelena Rascon
Journal:  Acta Med Litu       Date:  2017

5.  Congenital neurodevelopmental anomalies in pediatric and young adult cancer.

Authors:  Jeannette R Wong-Siegel; Kimberly J Johnson; Katie Gettinger; Nicole Cousins; Nicole McAmis; Ashley Zamarione; Todd E Druley
Journal:  Am J Med Genet A       Date:  2017-08-29       Impact factor: 2.802

6.  Breastfeeding and the risk of childhood cancer: a systematic review and dose-response meta-analysis.

Authors:  Qing Su; Xiaohui Sun; Liwen Zhu; Qin Yan; Peiwen Zheng; Yingying Mao; Ding Ye
Journal:  BMC Med       Date:  2021-04-13       Impact factor: 8.775

7.  Temporal clustering of neuroblastic tumours in children and young adults from Ontario, Canada.

Authors:  Louise Hayes; Nermine Basta; Colin R Muirhead; Jason D Pole; Paul Gibson; Bruna Di Monte; Meredith S Irwin; Mark Greenberg; Deborah A Tweddle; Richard J Q McNally
Journal:  Environ Health       Date:  2022-03-07       Impact factor: 5.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.